Circulating sTREM-1 as a predictive biomarker of pediatric multisystemic inflammatory syndrome (MIS-C)
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- TREM-1 and its potential ligands in non-infectious diseases: from biology to clinical perspectivesPharmacology & Therapeutics, 2017
- Clinical Association of a Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) in Patients with Systemic Lupus ErythematosusImmunological Investigations, 2016
- sTREM‐1 in patients with chronic kidney disease on hemodialysisAPMIS, 2015
- Circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as diagnostic and prognostic marker in neonatal sepsisCytokine, 2014
- Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapyNature Reviews Immunology, 2013
- Levels of Plasma-soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) Are Correlated with Disease Activity in Rheumatoid ArthritisThe Journal of Rheumatology, 2012
- Plasmodium falciparum-Infected Erythrocytes and IL-12/IL-18 Induce Diverse Transcriptomes in Human NK Cells: IFN-α/β Pathway versus TREM SignalingPLOS ONE, 2011
- Dynamic changes of serum soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) reflect sepsis severity and can predict prognosis: a prospective studyBMC Infectious Diseases, 2011
- Metalloproteinases Shed TREM-1 Ectodomain from Lipopolysaccharide-Stimulated Human MonocytesThe Journal of Immunology, 2007
- TREM‐1 (Triggering Receptor Expressed on Myeloid Cells): A New Player in Acute Inflammatory ResponsesThe Journal of Infectious Diseases, 2003